vs
Side-by-side financial comparison of BioAge Labs, Inc. (BIOA) and Heritage Distilling Holding Company, Inc. (IPST). Click either name above to swap in a different company.
Heritage Distilling Holding Company, Inc. is the larger business by last-quarter revenue ($4.7M vs $3.1M, roughly 1.5× BioAge Labs, Inc.). BioAge Labs, Inc. runs the higher net margin — -842.9% vs -6862.0%, a 6019.1% gap on every dollar of revenue.
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. Russian-born technology businessman Yuri Milner, along with investors including Jeff Bezos, funded the company in 2021, operations started in 2022.
Newport Craft Brewing & Distilling Company is a brewery and distillery located in Newport, Rhode Island. Established in 1999 as the Coastal Extreme Brewing Company, it was the first microbrewery in Newport and began distilling operations in 2006. The company produces a range of beers and spirits that are distributed in the Northeastern United States. In 2018 it adopted its current name to reflect its combined brewing and distilling operations. Newport Craft is owned by Audrain Hospitality Gro...
BIOA vs IPST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.1M | $4.7M |
| Net Profit | $-25.9M | $-323.7M |
| Gross Margin | — | 68.5% |
| Operating Margin | -923.4% | -2622.6% |
| Net Margin | -842.9% | -6862.0% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.72 | $-31.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.1M | $4.7M | ||
| Q3 25 | $2.1M | $3.0M | ||
| Q2 25 | $2.4M | $1.3M | ||
| Q1 25 | $1.5M | $1.1M | ||
| Q3 24 | $0 | $1.8M |
| Q4 25 | $-25.9M | $-323.7M | ||
| Q3 25 | $-20.2M | $196.3M | ||
| Q2 25 | $-21.6M | $-7.3M | ||
| Q1 25 | $-12.9M | $-3.0M | ||
| Q3 24 | $-23.4M | $-3.4M |
| Q4 25 | — | 68.5% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 24.9% | ||
| Q3 24 | — | 35.8% |
| Q4 25 | -923.4% | -2622.6% | ||
| Q3 25 | -1126.6% | -38.4% | ||
| Q2 25 | -1027.0% | -503.0% | ||
| Q1 25 | -1133.4% | -224.5% | ||
| Q3 24 | — | -118.1% |
| Q4 25 | -842.9% | -6862.0% | ||
| Q3 25 | -982.0% | 6566.2% | ||
| Q2 25 | -894.0% | -551.9% | ||
| Q1 25 | -891.0% | -277.8% | ||
| Q3 24 | — | -194.9% |
| Q4 25 | $-0.72 | $-31.89 | ||
| Q3 25 | $-0.56 | $16.97 | ||
| Q2 25 | $-0.60 | $-0.77 | ||
| Q1 25 | $-0.36 | $-0.34 | ||
| Q3 24 | $-6.70 | $-160.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $281.1M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $272.1M | $98.2M |
| Total Assets | $294.9M | $108.8M |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $281.1M | — | ||
| Q3 25 | $285.8M | — | ||
| Q2 25 | $297.3M | — | ||
| Q1 25 | $320.5M | — | ||
| Q3 24 | $334.5M | — |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | $7.1M | $13.0M | ||
| Q3 24 | $9.9M | $15.0M |
| Q4 25 | $272.1M | $98.2M | ||
| Q3 25 | $277.5M | $420.4M | ||
| Q2 25 | $294.8M | $-2.9M | ||
| Q1 25 | $313.2M | $-329.0K | ||
| Q3 24 | $313.7M | $-34.0M |
| Q4 25 | $294.9M | $108.8M | ||
| Q3 25 | $305.1M | $482.8M | ||
| Q2 25 | $322.1M | $26.5M | ||
| Q1 25 | $343.8M | $27.1M | ||
| Q3 24 | $337.4M | $31.1M |
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.02× | — | ||
| Q3 24 | 0.03× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-28.3M | $-7.5M |
| Free Cash FlowOCF − Capex | $-28.4M | — |
| FCF MarginFCF / Revenue | -921.5% | — |
| Capex IntensityCapex / Revenue | 3.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-82.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-28.3M | $-7.5M | ||
| Q3 25 | $-16.0M | $-4.3M | ||
| Q2 25 | $-20.0M | $-1.5M | ||
| Q1 25 | $-17.4M | $-2.0M | ||
| Q3 24 | — | — |
| Q4 25 | $-28.4M | — | ||
| Q3 25 | $-16.1M | $-4.3M | ||
| Q2 25 | $-20.1M | $-1.5M | ||
| Q1 25 | $-17.8M | $-2.0M | ||
| Q3 24 | — | — |
| Q4 25 | -921.5% | — | ||
| Q3 25 | -782.2% | -144.7% | ||
| Q2 25 | -834.5% | -115.3% | ||
| Q1 25 | -1226.0% | -187.6% | ||
| Q3 24 | — | — |
| Q4 25 | 3.6% | 0.0% | ||
| Q3 25 | 1.1% | 1.5% | ||
| Q2 25 | 6.6% | 0.9% | ||
| Q1 25 | 29.4% | 1.6% | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOA
Segment breakdown not available.
IPST
| Direct To Consumer | $3.0M | 63% |
| Wholesale | $1.2M | 26% |
| Other | $517.7K | 11% |
